Cipla inches up on the BSE

22 Feb 2023 Evaluate

Cipla is currently trading at Rs. 966.55, up by 0.60 points or 0.06% from its previous closing of Rs. 965.95 on the BSE.

The scrip opened at Rs. 966.00 and has touched a high and low of Rs. 968.95 and Rs. 959.45 respectively. So far 22902 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1185.20 on 01-Nov-2022 and a 52 week low of Rs. 880.00 on 24-Feb-2022.

Last one week high and low of the scrip stood at Rs. 1037.50 and Rs. 956.20 respectively. The current market cap of the company is Rs. 77937.82 crore.

The promoters holding in the company stood at 33.61%, while Institutions and Non-Institutions held 49.47% and 16.91% respectively.

The United States Food and Drug Administration (USFDA) has conducted a current Good Manufacturing Practices (cGMP) inspection at Cipla’s Pithampur manufacturing facility from February 6 - 17, 2023. On conclusion of the inspection, the Company has received 8 inspectional observations in Form 483. The Company will work closely with the USFDA and is committed to address these comprehensively within stipulated time.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.


Cipla Share Price

1501.80 -3.25 (-0.22%)
29-Dec-2025 11:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.60
Dr. Reddys Lab 1262.95
Cipla 1501.80
Zydus Lifesciences 905.45
Lupin 2092.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×